LLY or NVO? With surging GLP-1 sales, oral obesity pills and diverging 2026 outlooks, the obesity drug race is entering a pivotal new phase.
MiniMed Group, the diabetes business of Medtronic, filed Tuesday to raise up to $784 million in an initial public offering. The Northridge, California-based firm p ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results